BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Mar 21, 2016
Financial News

Laurent Pharmaceuticals completes venture financing

...Montreal, Quebec Business: Pulmonary Date completed: 2016-03-17 Type: Venture financing Raised: Not disclosed Investors: Cystic Fibrosis Canada...
Items per page:
1 - 2 of 2
BioCentury | Jan 5, 2019
Finance

Ready to launch

The proposed $74 billion takeout of Celgene Corp. by Bristol-Myers Squibb Co. will not shift buysider attention away from upcoming and maturing drug launches heading into 2019, with plenty to track following a record year...
BioCentury | Mar 21, 2016
Financial News

Laurent Pharmaceuticals completes venture financing

...Montreal, Quebec Business: Pulmonary Date completed: 2016-03-17 Type: Venture financing Raised: Not disclosed Investors: Cystic Fibrosis Canada...
Items per page:
1 - 2 of 2